Minimum Investment
₹14,526
Price Range
₹768 to ₹807
Lot Size
18 shares
Issue Size
₹940 Cr
Incorporated in 2000, Molbio Diagnostics Limited is a point-of-care (“POC”) diagnostics company focused on delivering accurate, rapid, and cost-effective healthcare technologies for infectious and non-communicable diseases.
Bookbuilding IPO
| Bid/Offer Opens On | 10-08-2026 |
| Bid/Offer Closes On | 12-08-2026 |
| Finalisation of Basis of Allotment | 13-08-2026 |
| Initiation of Refunds | 14-08-2026 |
| Credit of Shares to Demat | 14-08-2026 |
| IPO Listing Date | 17-08-2026 |
| Category | Offered Shares | Applied Shares | Times |
|---|---|---|---|
| QIB | 2,325,146 | 433,382,148 | 186.39x |
| NII | 1,743,859 | 86,840,604 | 49.80x |
| NII ( >10 lakh) | 1,162,573 | 59,076,594 | 50.82x |
| NII ( <10 lakh) | 581,286 | 27,764,010 | 47.76x |
| Retail | 4,069,004 | 52,719,318 | 12.96x |
| Employee | 20,520 | 272,466 | 13.28x |
| Total | 8,158,529 | 573,214,536 | 70.26x |
The lot size is 18 shares with a minimum investment of ₹14,526.
Bidding is scheduled from 10-08-2026 to 12-08-2026 (subject to exchange updates).
You can apply via the IPO Focuss - Ambica Finstock LLP mobile app during the bidding window using UPI or ASBA as available for this issue.
Shares are expected to list on 17-08-2026 (tentative; confirm from RHP / exchange notices).
Kfin Technologies Ltd.